Publisher
Springer Berlin Heidelberg
Reference51 articles.
1. Anderson H, Hopwood P, Stephens RJ et al. (2000) Gemcitabine plus best supportive care (BSC) vs. BSC in inoperable non-small cell lung cancer — a randomized trial with quality of life as the primary outcome. Br J Cancer 83:447–453
2. Antman KH, Pass HI, Schiff PB (2001) Management of mesothelioma. In: DeVita VT Jr, Hellman S, Rosenberg SA (eds) Cancer — principles an practice of oncology, 6th edn. Lippincott, Williams & Wilkins, Philadelphia, pp 1943–1969.
3. Ardizzoni A, Hansen H, Dombernowsky P et al. (1997) Topotecan, a new active drug in the second-line treatment of small-cell lung cancer: a phase II study in patients with refractory and sensitive disease. J Clin Oncol 15:2090–2096
4. Auperin A, Arriagada R, Pignon JP et al. (1999) Prophylactic cranial irradiation for patients with small-ceil lung cancer in complete remission. New Engl J Med 341:476–484
5. Becker N, Wahrendorf J (1998) Krebsatlas der Bundesrepublik Deutschland, 3. Aufl.Springer, Berlin Heidelberg NewYorkTokyo